Abstract
OBJECTIVE: Leptin is primarily produced in adipose tissue and appears to play a modulatory role between metabolism and immunity. Given that obesity, a state of chronic inflammation, is an established risk factor for Renal Cell Carcinoma (RCC), we investigated the association between plasma leptin levels and RCC risk. DESIGN: This case-control study included 70 patients with newly diagnosed, histologically confirmed RCC and 280 age-, gender- and district of residence-matched controls. Anthropometric data, socio-demographic variables, medical history, lifestyle habits and dietary data were derived from a personal interview. Serum leptin and adiponectin levels were determined using standard commercial kits. Adjusted odds ratios for RCC risk were derived through multiple logistic regression analyses. RESULTS: Leptin levels were inversely associated with RCC risk (OR: 0.53, CI: 0.28–0.99, p = 0.05), even after controlling for potential confounding factors, such as Body Mass Index (BMI), recent weight change, history of diabetes mellitus and other obesity related hormones, notably adiponectin. CONCLUSIONS: The precise mechanism linking obesity with RCC remains unclear; however, the inverse association of leptin with RCC might be attributed, at least in part, to hormonal cross-talk with complex neuron-endocrine and immune circuits. These findings, if confirmed in prospective and interventional studies, might further elucidate the underlying mechanisms.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lipworth L, Tarone RE, McLaughlin JK, 2006 The epidemiology of renal cell carcinoma. J Urol 176: 2353–2358.
Matarese G, Moschos S, Mantzoros CS, 2005 Leptin in Immunology. J Immunol 173: 3137–3142.
Shamsuzzaman AS, Winnicki M, Wolk R, et al, 2004 Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109: 2181–2185.
De Rosa V, Procaccini C, Gaetano C, et al, 2007 A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241–255.
La Cava A, Alviggi C, Matarese G, 2004 Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82: 4–11.
Horiguchi A, Sumitomo M, Asakuma J, et al, 2006 Increased serum levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 176: 1631–1635.
Horiguchi A, Sumitomo M, Asakuma J, et al, 2006 Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol 176: 1636–1641.
Attoub S, Noe V, Pirola L, et al, 2000 Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. Faseb J 14: 2329–2338.
Spyridopoulos TN, Petridou E. Th, Skalkidou A, et al, 2007 Low adiponectin levels are associated with renal carcinoma: A case-control study. Int J Cancer 120: 1573–1578.
Gogas H, Trakatelli M, Dessypris N, et al, 2008 Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol 19: 384–389.
Gnardellis C, Trichopoulou A, Katsouyanni K, Polychronopoulos E, Rimm EB, Trichopoulos D, 1995 Reproducibility and validity of an extensive semiquantitative food frequency questionnaire among Greek school teachers. Epidemiology 6: 74–77.
Petridou E, Kedikoglou S, Koukoulomatis P, et al, 2002 Diet in relation to endometrial cancer risk: a case-control study in Greece. Nutr Cancer 44: 16–22.
Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos A, the Childhood Hematology-Oncology Group, 2005 Maternal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev 14: 1935–1939.
Gavrila A, Chan JL, Yiannakouris N, et al, 2003 Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting of leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88: 4823–4831.
SAS Institute Inc. 1989 SAS/STAT User’s Guide, Version 6, 4th Ed. Cary NC.
Petridou E, Papadiamantis Y, Markopoulos C, et al, 2000 Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11: 383–388.
Petridou E, Belechri M, Dessypris N, et al, 2002 Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 46: 147–151.
Stattin P, Lukanova A, Biessy C, et al, 2004 Obesity and colon cancer: does leptin provide a link? Int J Cancer 109: 149–152.
Stattin P, Soderberg S, Hallmans G, et al, 2001 Leptin is associated with increased prostate risk: a nested case-referent study. J Clin Endocrinol Metab 86: 1341–1345.
Steiner AA, Romanovsky AA, 2007 Leptin: At the crossroads of energy balance and systemic inflammation. Prog Lipid Res 46: 89–107.
Pinkney JH, Coppack SW, Mohamed-Ali V, 1998 Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol 48: 407–411.
Federico A, Morgillo F, Tuccillo C, et al, 2007 Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381–2386.
Parker A, Cerhan JR, Lynch CF, et al, 2004 History of Urinary Tract Infection and Risk of Renal Cell Carcinoma. Am J Epidemiol 159: 42–48.
Bukur J, Malenica B, Huber C, Seliger B, 2003 Altered expression of nonclassical HLA class 1B antigens in human renal cell carcinoma and its association with impaired immune response. Human Immunology 64: 1081–1092.
Hu X, Juneja SC, Maihle NJ, et al, 2002 Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704–1711.
Oelmann E, Haghgu S, Kulimova E, et al, 2003 Re: Leptin: a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 95: 1171–1173.
Elinav E, Abd-Elnabi A, Pappo O, et al, 2006 Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol 44: 529–536.
Nave H, Mueller G, Siegmund B, et al, 2008 Resistance of JAK-2 dependent leptin signaling in NK cells — a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology doi: 10. 1210/en. 2007-1516.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Members of the Obesity and Cancer Oncology Group in the Renal Cancer study: a) A. Giannopoulos, 1st Department of Urology, Athens University Medical School, b) G. Alivizatos, 2nd Department of Urology, Athens University Medical School, “Sismanoglion Hospital”, c) G. Vassilakis, Department of Urology, General Hospital of Athens “G. Gennimatas”, d) T. Kalogeropoulos, Department of Urology, “Saint Savas” Anticancer Hospital, Athens, Greece
Rights and permissions
About this article
Cite this article
Spyridopoulos, T.N., Petridou, E.T., Dessypris, N. et al. Inverse association of leptin levels with renal cell carcinoma: Results from a case-control study. Hormones 8, 39–46 (2009). https://doi.org/10.14310/horm.2002.1220
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1220